Back to mobile site

Summer Street Affirms Netural Rating on Gilead (GILD); Early Sovoldi Buy-In May Produce Softer Results

February 5, 2014 9:35 AM EST Send to a Friend
Summer Street is still Neutral on Gilead Sciences (Nasdaq: GILD) following Q4 results reported Tuesday night.

Analyst Carol Werther ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login